1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LIQUIDIA CORP
Liquidia Corp
XNAS: LQDA

Liquidia Corp Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hyperte...

Read More
36.66 -0.92 (-2.45%)
225.58% Gain from 52W Low
1.8M
XNAS Volume

XNAS 13 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Liquidia Corp is on 19 Mar 2026 for the purpose of Liquidia Corp Fourth Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
3.8 / 100
Momentum Score
Technically Neutral
59.3 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
50
1Yr Price target upside is 36%
9 analysts

9

S

14

W

5

O

0

T

SWOT Analysis

Liquidia Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..